The next-generation of Point-of-care blood testing (POCT)
Consumables cartridge testsDevice
One compact device for multiple diagnostics tests with a single drop of blood
Single use cartridges, Nespresso-like business model
Designed for minimally-trained operators
Perfect match between clinical accuracy and consumer design
Integrated cloud services for real-time 3G data reporting
Diagnostics of Dengue fever
Dengue is growing worldwide and has huge need of better diagnostics tools
Mosquito-born disease with 4 virus forms, dengue affects 120 countries and 390M people/year
Spread of Dengue fever worldwide
Dengue fever has increased 30-fold over the past 4 decades
Outside Africa, dengue’s impact on society is already larger than malaria
UrbanizationClimate change Movement of people
Dengue fever vaccine just released from Sanofi-Pasteur
Introduction of vaccines completely change the diagnostics landscape, making
current rapid testing tools obsolete
Dec 8th 2015 – Approved in MexicoDec 22nd 2015 – Approved in BrazilJan 8th 2016 – Approved in Philippines
2016-2017 – Expected approval in Malaysia, Indonesia, Thailand, Vietnam, Singapore, Colombia, Peru
Dengvaxia vaccine
Outbreaks expected to grow demand for better diagnostics tools
http://www.economist.com/blogs/graphicdetail/2016/01/daily-chart-19
http://www.theguardian.com/world/2016/jan/25/zika-virus-likely-spread-throughout-americas-says-who
http://www.reuters.com/article/us-health-zika-obama-idUSKCN0V50DM
https://www.safetravel.govt.nz/news/dengue-fever-chikungunya-and-zika-virus-pacific-islands
€0
€100.000.000
€200.000.000
€300.000.000
€400.000.000
€500.000.000
€600.000.000
€700.000.000
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029
Dengue blood testing market forecast
Diagnostics of clinical cases
Post-vaccination monitoring
Increase in dengue cases and introduction of vaccines will drive dengue testing market growth until 2030
Dengue fever blood testing market forecast
TrackDengue – Next-generation Dengue diagnostics device
Quantitative diagnostics of dengue fever
TrackDengue products: portable device, multiple cartridges and real-time cloud services.
Integrating multiple mosquito-borne diseases diagnostics
Enabling critical diagnosis of severe mosquito-borne diseases
Aedes Aegypti is carrier for three different virus:
Dengue
Chikungunya
Zika virus
3 tests in one drop of blood
• Dengue IgG• Chikungunya IgG• Zika IgG
The three diseases are often confused by symptoms
Clinical decision requires identification of infection
Mapping virus is imperative to contain outbreaks
Endorsement from key stakeholders
http://www.breakdengue.org/rapid-new-test-could-transform-dengue-diagnostics/
Endorsement from government organizations and NGOs
http://www.nature.com/articles/srep16145
BluSense market focus
BluSense focuses its products distribution in South East Asian region
South East Asia has the largest dengue burden
Grants(€1M)
Round A (€3M) Round B (€4M) Round C
From concept to prototype
From product to revenue
From prototype to product
From revenue to profitability
EXIT
2012 2014 2016 2018 2020
Financing timeline
Trade sale or IPO Target > EUR 300MROI > 10
5-years Exit Strategy